Cayuga Biotech

Medtech · Private

Biomimetic hemorrhage control device for trauma and surgical bleeding

cayugabiotech.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
$483K
1 award · Defense
#385 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Defense · Igf::ot::igf - Bto Studies - Ffp Contract Award For "accelerating Coagulation In Traumatic Injuries Using Inorganic Polyphosphate-coated Silica Nanoparticles"$483,009
Federal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
382BARRETT TECHNOLOGY, LLC$505K—
383KLAR SCIENTIFIC, INC.$492K$120K
384ENCISION INC$485K$3.4M
385Cayuga Biotech$483K—
386ELUTIA INC.$472K$55M
387INTELLIGENT PROSTHETIC SYSTEMS, LLC$460K—
388CIRCADIAN POSITIONING SYSTEMS INC$457K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Polyphosphate-functionalized Nanoparticles And Methods Of Useapplication
  • Polyphosphate-functionalized Nanoparticles And Methods Of Useapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.